PFIZER INC. (LON:PFZ) Files An 8-K Other EventsItem 8.01 Other Events
On December 7, 2018, Pfizer Inc. (“Pfizer”) issued a notice for the redemption in full of all €1,141,300,000 aggregate principal amount outstanding of its 5.750 per cent. Notes due 2021 (ISIN: XS0432071131; COMMON CODE: 043207113) (the “Notes”).
The Notes will be redeemed on January 9, 2019 at a “make-whole” redemption price as set forth in the indenture, as supplemented, to which the Notes were issued. On the redemption date, the redemption price will become due and payable on the Notes and, unless Pfizer defaults in the payment of the redemption price, interest on the Notes will cease to accrue on and after the redemption date. The notice of redemption specifying the terms, conditions and procedures for the redemption is available through The Bank of New York Mellon, located at 240 Greenwich St., New York, New York 10286, as paying agent for the Notes. The foregoing does not constitute a notice of redemption for the Notes.
